Breaking News Instant updates and real-time market news.

GTHX

G1 Therapeutics

$33.93

0.29 (0.86%)

12:35
09/29/19
09/29
12:35
09/29/19
12:35

G1 Therapeutics to host conference call

Management reviews the data being presented at ESMO 2019, as well as long-range development and commercial plans for all three of its clinical-stage therapies, on a conference call to be held on September 29 at 12:45 pm. Webcast Link

  • 29

    Sep

  • 02

    Oct

GTHX G1 Therapeutics
$33.93

0.29 (0.86%)

02/07/19
RILY
02/07/19
INITIATION
Target $55
RILY
Buy
G1 Therapeutics initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Harshita Polishetty started G1 Therapeutics with a Buy rating and $55 price target.
02/07/19
RILY
02/07/19
INITIATION
Target $55
RILY
Buy
B. Riley FBR starts G1 Therapeutics with Buy rating, $55 price target
B. Riley FBR analyst Harshita Polishetty initiated coverage of G1 Therapeutics with a Buy rating and $55 price target. G1's lead candidate, trilaciclib, has the potential to address myelotoxicity and improve overall survival in chemotherapy-associated treatment regimens, Polishetty tells investors in a research note. Further, Lerociclib, although fourth to market, demonstrates potential to be best in class given its clean safety profile thus far adds the analyst. She also believes G1T48 allows for competitive pricing when both lerociclib and G1T48 hit the market.
06/18/19
HCWC
06/18/19
NO CHANGE
HCWC
G1 Therapeutics trial results 'important,' says H.C. Wainwright
H.C. Wainwright analyst Edward White maintained a Buy rating and $71 price target on G1 Therapeutics. The analyst noted that G1 Therapeutics' topline OS improvements from its randomized, open-label Phase 2 trial evaluating trilaciclib in metastatic triple-negative breast cancer were "statistically significant in both treatment arms compared with the control arm." White believes that "an OS benefit seen in a small three-arm trial like this is an important result" and added that "the company can now pursue an efficacy benefit as well as the myelopreservation pathway... for commercialization."
08/08/19
JPMS
08/08/19
UPGRADE
Target $45
JPMS
Overweight
G1 Therapeutics upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Anupam Rama upgraded G1 Therapeutics to Overweight from Neutral and raised his price target for the shares to $45 from $38. The analyst sees a "string of important key catalysts" in the second half of 2019 and first half of 2020 for G1's pipeline. Rama now includes G1T48 in his model with initial phase 1 data in ER+/HER2- breast cancer coming at the end of September. Further, at current share levels, the analyst believes limited value is being ascribed to lerociclib.

TODAY'S FREE FLY STORIES

AER

AerCap

$56.60

0.65 (1.16%)

, BA

Boeing

$331.12

-12.97 (-3.77%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Hot Stocks
AerCap delivers new Boeing 787-9 Dreamliner to Air New Zealand »

AerCap Holdings (AER) has…

AER

AerCap

$56.60

0.65 (1.16%)

BA

Boeing

$331.12

-12.97 (-3.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 08

    Nov

JBLU

JetBlue

$17.54

0.59 (3.48%)

07:06
10/22/19
10/22
07:06
10/22/19
07:06
Earnings
JetBlue backs FY20 EPS view of $2.50-$3.00, consensus $2.36 »

"We are gaining…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 10

    Nov

SHW

Sherwin-Williams

$551.04

-9.93 (-1.77%)

07:05
10/22/19
10/22
07:05
10/22/19
07:05
Earnings
SHW raised FY19 adjusted EPS view to $20.90-$21.30 from $20.40-$21.40 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

RCKT

Rocket Pharmaceuticals

$13.63

0.35 (2.64%)

07:05
10/22/19
10/22
07:05
10/22/19
07:05
Hot Stocks
Rocket Pharmaceuticals announces FDA clearance of RP-L301 IND »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GOOG

Alphabet

$1,246.23

-0.33 (-0.03%)

, GOOGL

Alphabet Class A

$1,244.23

-0.57 (-0.05%)

07:05
10/22/19
10/22
07:05
10/22/19
07:05
Recommendations
Alphabet, Alphabet Class A, Facebook, Twitter analyst commentary  »

Ad spending across major…

GOOG

Alphabet

$1,246.23

-0.33 (-0.03%)

GOOGL

Alphabet Class A

$1,244.23

-0.57 (-0.05%)

FB

Facebook

$189.82

3.865 (2.08%)

TWTR

Twitter

$40.09

1.11 (2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

UPS

UPS

$118.56

1.23 (1.05%)

07:05
10/22/19
10/22
07:05
10/22/19
07:05
Hot Stocks
UPS sees FY19 adjusted free cash flow over $4B »

"UPS delivered solid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

07:05
10/22/19
10/22
07:05
10/22/19
07:05
General news
FX Update: The dollar managed to lift against most currencies »

FX Update: The dollar…

AVRO

Avrobio

$14.18

0.38 (2.75%)

07:04
10/22/19
10/22
07:04
10/22/19
07:04
Hot Stocks
Avrobio appoints Holly May as Chief Commercial Officer »

Avrobio announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABG

Asbury Automotive

$106.00

2.63 (2.54%)

07:04
10/22/19
10/22
07:04
10/22/19
07:04
Hot Stocks
Asbury Automotive reports Q3 same store results »

Q3 same store: Total…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 05

    Dec

JBLU

JetBlue

$17.54

0.59 (3.48%)

07:04
10/22/19
10/22
07:04
10/22/19
07:04
Hot Stocks
JetBlue sees Q4 capacity up 4.5%-6.5%, FY19 up 6%-7% »

For Q4, capacity is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 10

    Nov

UPS

UPS

$118.56

1.23 (1.05%)

07:03
10/22/19
10/22
07:03
10/22/19
07:03
Earnings
Breaking Earnings news story on UPS »

UPS reaffirms FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

JBLU

JetBlue

$17.54

0.59 (3.48%)

07:03
10/22/19
10/22
07:03
10/22/19
07:03
Earnings
JetBlue reports Q3 adjusted EPS 59c, consensus 52c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 10

    Nov

UTX

United Technologies

$138.24

1.39 (1.02%)

07:03
10/22/19
10/22
07:03
10/22/19
07:03
Earnings
United Technologies raises FY19 adj. EPS view to $8.05-8.15 from $7.90-$8.05 »

Consensus $8.03. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

ABG

Asbury Automotive

$106.00

2.63 (2.54%)

07:03
10/22/19
10/22
07:03
10/22/19
07:03
Earnings
Asbury Automotive reports Q3 EPS $2.33, consensus $2.32 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 05

    Dec

BIIB

Biogen

$223.57

3.52 (1.60%)

, ALKS

Alkermes

$18.41

0.24 (1.32%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Hot Stocks
Biogen preparing to launch Vumerity for multiple sclerosis »

Biogen (BIIB) said in its…

BIIB

Biogen

$223.57

3.52 (1.60%)

ALKS

Alkermes

$18.41

0.24 (1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 06

    Nov

NVS

Novartis

$86.55

-0.305 (-0.35%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Hot Stocks
Breaking Hot Stocks news story on Novartis »

Novartis reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Dec

SHW

Sherwin-Williams

$551.04

-9.93 (-1.77%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Earnings
Sherwin-Williams reports Q3 EPS ex-items $6.65, consensus $6.48 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

UPS

UPS

$118.56

1.23 (1.05%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Earnings
UPS reports Q3 adjusted EPS $2.07, consensus $2.06 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

NVS

Novartis

$86.55

-0.305 (-0.35%)

07:02
10/22/19
10/22
07:02
10/22/19
07:02
Earnings
Novartis raises FY19 net sales view to up high single digits »

Previous guidance was up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Dec

TRV

Travelers

$141.77

0.33 (0.23%)

07:01
10/22/19
10/22
07:01
10/22/19
07:01
Hot Stocks
Travelers reports Q3 adjusted book value $90.09, up 3% from last year »

Reports Q3 underlying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MDR

McDermott

$2.04

-0.3 (-12.82%)

07:01
10/22/19
10/22
07:01
10/22/19
07:01
Hot Stocks
McDermott awarded 'large' contract for mixed feed cracker in Saudi Arabia »

McDermott announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.18

0.16 (0.30%)

07:00
10/22/19
10/22
07:00
10/22/19
07:00
Hot Stocks
Bristol-Myers: CheckMate -9LA Phase 3 trial met primary endpoint »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 06

    Nov

  • 18

    Nov

NVS

Novartis

$86.55

-0.305 (-0.35%)

07:00
10/22/19
10/22
07:00
10/22/19
07:00
Earnings
Novartis reports Q3 core EPS $1.41, consensus $1.33 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Dec

TRV

Travelers

$141.77

0.33 (0.23%)

07:00
10/22/19
10/22
07:00
10/22/19
07:00
Earnings
Travelers reports Q3 core income $1.43, consensus $2.35 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PG

Procter & Gamble

$119.04

1.55 (1.32%)

06:59
10/22/19
10/22
06:59
10/22/19
06:59
Hot Stocks
Procter & Gamble reports Q1 operating cash flow $4.2B »

Operating cash flow was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.